20 June 2024

EULAR

EULAR 2024 highlights

30 November 2023

EULAR Management

New guidelines for managing fatigue in rheum patients

15 June 2023

EULAR Rheumatoid Arthritis

Shingrix immunogenicity in RA patients

8 June 2023

EULAR Technology

What can AI do for rheum?

8 June 2023

Anti JAKS Biologics EULAR Rheumatoid Arthritis

JAKis don’t beat TNFis in high-risk patients

8 June 2023

EULAR MTX Pregnancy

MTX is okay for sperm

5 June 2023

EULAR Public Health

Pearls of wisdom from cancer’s PR team

5 June 2023

Anti JAKS EULAR Rheumatoid Arthritis Sjogren Syndrom

Dual JAK1/TYK2 inhibitor outperforms tofacitinib

5 June 2023

EULAR Lupus Psoriatic Athritis

JAKi fallout reaches PsA guidelines

5 June 2023

EULAR Lupus Osteoporosis

Aussie researchers at EULAR

5 June 2023

Anti JAKS EULAR Rheumatoid Arthritis

CV and cancer risks with JAKi: EULAR perspectives

1 June 2023

EULAR Osteoarthritis

Good news for OA from EULAR

1 June 2023

EULAR Osteoarthritis

Sliver of hope for hand OA

1 June 2023

EULAR Spondyloarthritis

EULAR refocuses on coalface patient care

25 May 2023

EULAR

EULAR 2023 preview

13 April 2023

EULAR

EULAR 2023 from home